Valbenazine Production Cost Reports

The report provides a detailed analysis essential for establishing a Valbenazine production plant. It encompasses all critical aspects necessary for Valbenazine production, including the cost of Valbenazine production, Valbenazine plant cost, Valbenazine production costs, and the overall Valbenazine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Valbenazine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Valbenazine is a once-daily oral medicine that is used to treat involuntary movements. It is utilized in managing tardive dyskinesia caused by long-term use of antipsychotic and other dopamine blocking drugs, and chorea in Huntington's disease. It works by blocking a brain protein, which lowers the amount of dopamine released between nerve cells. This helps calm down the extra, unwanted movements without strongly affecting most other brain receptors. It is taken once a day, and shows noticeable improvement in abnormal movements within a few weeks. Its common side effects include sleepiness, tiredness, dry mouth, and sometimes balance problems or falls, while more serious but less common risks include changes in heart rhythm and mood or behavior changes.

The market for Valbenazine is influenced by growing cases of tardive dyskinesia (TD). The rising antipsychotic prescriptions for schizophrenia and mood disorders contribute to its market growth.  Its utilization in different disorders like Huntington's chorea is fuelled by better diagnosis and awareness. The industrial Valbenazine procurement is driven by high drug pricing and reimbursement challenges. The improvements against costs, influenced by value-based purchasing models, regulatory approvals, supply chain reliability for API production, and competition from deutetrabenazine, further affect its sourcing. Also, patient assistance programs and economic pressures on drug spending that prioritize long-term outcomes and negotiated discounts impact its market dynamics.

Raw Material for Valbenazine Production

According to the Valbenazine production plant project report, the key raw materials used in the production of Valbenazine include tetrahydroisoquinoline-derived nitrone and methyl but-3-enoate.

Production Process of Valbenazine

The extensive Valbenazine production cost report consists of the following major industrial production process:

1. From Tetrahydroisoquinoline-Derived Nitrone: The production of Valbenazine involves a cycloaddition reaction. In this method, a tetrahydroisoquinoline-based nitrone reacts with methyl but-3-enoate to form a bicyclic intermediate with good control over stereochemistry. This intermediate is then treated to remove the N–O bond and undergoes ring closure to give a lactam compound. The lactam is further modified by alkylation and reduction steps to produce racemic HTBZ. The required enantiomer is obtained either by enzymatic separation using a lipase enzyme or after chemical resolution during valine coupling. The purified HTBZ is then reacted with protected L-valine using standard coupling reagents to form Valbenazine.

Valbenazine is a synthetic small-molecule prodrug with the chemical formula C24H38N2O4 and a molecular weight of 418.57 g/mol. It is a light yellow to yellow hygroscopic solid powder that shows low aqueous solubility. It has good solubility in organic solvents like DMSO, DMF, and ethanol, with limited solubility in chloroform and methanol mixtures. It has a pKa value of 7.76, an estimated logP of 3.88, indicating moderate lipophilicity. It has one hydrogen bond donor, five acceptors, and a topological polar surface area of 74.02 Ų. Its boiling point is around 507 degree Celsius and its density is 1.11 g/cm³. It decomposes above 75 degree Celsius under inert storage conditions at -20 degree Celsius.